Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Chondroitin sulfate - IBSA

Next Previous
X
Search
Drug Profile

Chondroitin sulfate - IBSA

Alternative Names: Chondroitin 4-sulfate - IBSA; Chondroitin 4-sulfate sodium - IBSA; Chondroitin 6-sulfate - IBSA; Chondroitin 6-sulfate sodium - IBSA; Chondroitin sulfate A - IBSA; Chondroitin sulfate A sodium - IBSA; Chondroitin sulfate sodium - IBSA; Chondroitin sulphate - IBSA; Chondrosulf; Condrosulf (IBSA); Condrosulf (Salus Braumapharm)

Latest Information Update: 19 Oct 2023

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator IBSA
  • Developer IBSA; Laboratoires Genevrier; Sanova Pharma; SPA
  • Class Anti-inflammatories; Antirheumatics; Glycosaminoglycans
  • Mechanism of Action Collagen stimulants; Leucocyte elastase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Osteoarthritis

Most Recent Events

  • 05 Oct 2023 IBSA withdraws a phase III MOTION trial for Osteoarthritis (In adults, In the elderly) (PO), prior to enrolment (NCT05632783)
  • 01 Dec 2022 IBSA plans a phase III trial for Osteoarthritis in April 2023 (PO, Tablet) (NCT05632783)
  • 01 Mar 2022 Discontinued - Phase-III for Osteoarthritis in Poland, Belgium (PO)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top